BLFS · Healthcare · $1.9B
$38.85-0.94%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 44 Medical - Instruments & Supplies peers
Quarterly Revenue Growth
“BioLife의 핵심 제품인 세포 보존 배지(BPM)가 전체 매출의 85% 이상을 차지하며, 현재 17개 승인 치료제에 탑재돼 있어요.”
In the company's words · 2026 1분기 earnings call